Gelatable compositions

The present invention relates to ophthalmologic compositions having gelation ability that contain polysaccharides and modified mono and/or bi terminated amino di- or tri- block copolymers. More particularly, the compositions of the present invention are composition for use in replacing ophthalmologi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LENDLEIN, ANDREAS, NEFFE, AXEL THOMAS, MESSNER, ARTHUR, KUGLER, WILFRIED, KAMLAGE, STEFAN, DILIPRAO, SANTAN HARSHAL
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F,C08G BANDAGES, DRESSINGS OR ABSORBENT PADS CHEMISTRY COMPOSITIONS BASED THEREON COMPOSITIONS OF MACROMOLECULAR COMPOUNDS DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION GENERAL PROCESSES OF COMPOUNDING HUMAN NECESSITIES HYGIENE MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC MACROMOLECULAR COMPOUNDS ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROSTHESES THEIR PREPARATION OR CHEMICAL WORKING-UP TREATMENT OR PROTECTION OF EYES OR EARS WORKING-UP
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to ophthalmologic compositions having gelation ability that contain polysaccharides and modified mono and/or bi terminated amino di- or tri- block copolymers. More particularly, the compositions of the present invention are composition for use in replacing ophthalmologic structures. The compositions are useful as a vitreous body substitute, particularly a vitreous body that acts as an artificial vitreous body having a tamponade effect. Hence, the present compositions are useful in ophthalmologic surgery and in the treatment of diseases that require replacing ophthalmologic structures.